COMMUNIQUÉS West-GlobeNewswire

Codexis to Present at Two Investment Conferences in November
09/11/2017
REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that management will present at two investment conferences in November: 8th Annual [...]
Nabriva Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
09/11/2017
- Positive topline results from pivotal LEAP 1 trial announced in September, with read-out from second Phase 3 trial, LEAP 2, expected in the spring of 2018 - - $112.7 million cash and investments as of September 30, [...]
BeyondSpring Reports Third Quarter 2017 Operational and Financial Results
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a pipeline of innovative [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Third Quarter 2017 Financial Results
09/11/2017
NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
TearLab Corporation Begins Trading on OTCQB
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that shares of its common stock will begin trading on the OTCQB Market, which is [...]
Recro Pharma Reports Third Quarter 2017 Financial Results
09/11/2017
NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN, Pa., Nov. 09, 2017 ( [...]
RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s Disease
09/11/2017
Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is evaluating the safety [...]
Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at 15th Action Duchenne International Conference
09/11/2017
New Preclinical Data Show Utrophin’s Positive Effect on Mitochondria Improving Muscle Health in DMD Model OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) the [...]
Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update
09/11/2017
TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD) today announced financial results for the three and nine months ended September 30, 2017, and provided a corporate update. Third Quarter [...]
ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board
09/11/2017
Key Updates Dr. Thaddeus (Ted) Dryja, a pioneer in the field of retinal genetic diseases, joins the Company’s Scientific Advisory Board. Dr. Dryja will play a key strategic role in the development and advancement of [...]
Purepoint Uranium Acquires Additional Claims, Tripling the Size of McArthur East Project
09/11/2017
TORONTO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX-V: PTU ) today reported the staking of 6 new claims adjacent to their 100% owned McArthur East project, [...]
Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results
09/11/2017
Top-line, 1-year Superiority Data for NeoCart ® Phase 3 Clinical Trial and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 Company to Host Conference Call and Webcast Thursday, [...]
Epizyme to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017
CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company [...]
INC Research/inVentiv Health Reports Third Quarter 2017 Results
09/11/2017
Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively. Combined Company adjusted net service revenue of $766.6 million and $2,331.6 [...]
Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
09/11/2017
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]
iSalus Healthcare Opens New Office in Downtown Indianapolis
09/11/2017
INDIANAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iSalus Healthcare, a premier healthcare technology and services company in Indiana, has recently moved offices to 1 Virginia Avenue, Suite 500, Indianapolis, IN 46204 . [...]
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
09/11/2017
NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced results [...]
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels
09/11/2017
Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9 [...]
Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
09/11/2017
TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]

Pages